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Editorial on the Research Topic
Reelin-Related Neurological Disorders and Animal Models
Homozygous, loss-of-function mutations in the mouse Reelin gene cause a severe neurological
phenotype known as reeler. These mutant mice exhibit marked cerebellar hypoplasia,
dyslamination of cortical and hippocampal cellular layers, and malposition of specific neuronal
populations in the brain stem and spinal cord. Similarly, homozygous mutations in the
very conserved human REELIN gene cause a severe neurodevelopmental disorder known as
lissencephaly with cerebellar hypoplasia (LCH). These structural defects underscore the essential
role that Reelin plays in the control of neuronal migration in the prenatal and early postnatal
brain. However, the Reelin protein also affects synapse formation and function in the postnatal and
adult brain, and this function is reflected in the manifestation of behavioral and cognitive deficits
in heterozygous reeler mice that express reduced levels of Reelin and do not exhibit overt brain
structural defects. A reduction in REELIN expression is also found in human patients affected by
neuropsychiatric disorders, including autism, schizophrenia, and depression. How does a deficit in
REELIN expression contribute to these diseases? In order to understand the potential role of Reelin
dysfunction in neuropsychiatric disorders we need to gain a deeper understanding of the molecular
mechanisms by which this protein controls all aspects of brain development and function. This
Research Topic is a collection of reviews that summarize and interpret many recent findings in the
Reelin field. The Topic also includes original research articles that provide novel information on
Reelin expression and function in different regions of the central nervous system.
Reelin is a large glycoprotein that is secreted by different neuronal populations at different
stages of brain development. Shortly after its discovery, it became clear that Reelin is subject to
proteolytic cleavage after secretion, resulting in the generation of multiple extracellular protein
fragments. The functional significance of this process was not well understood. In recent years,
several studies have shed some light on this event, identifying specific cleavage sites, and addressing
the consequence of proteolytic cleavage for Reelin biological function. Ranaivoson et al. review
structural aspects of Reelin as a ligand, discussing its proteolytic fragments, and the binding of
uncleaved and cleaved products to known cell surface receptors. Lussier et al. further review Reelin
proteolytic cleavage and its potential role in modulating synapse function in the normal adult
brain or in neurodegeneration. Two reviews then discuss in depth molecular aspects of Reelin
signal transduction that are initiated by distinct Reelin protein isoforms. Lee and D’Arcangelo
discuss how different Reelin ligands trigger different signaling pathways, and thus control different
functions such as neuronal migration, maturation, and synaptic activity. Bock and May further
review in depth canonical and non-canonical signaling pathways, emphasizing the role of different
pathways in the control of the neuronal cytoskeleton. Together, these reviews provide a detailed
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and comprehensive summary of the current state of the field’s
mechanistic understanding of Reelin signaling activities.
In the prenatal forebrain Reelin is expressed mainly by Cajal-
Retzius cells in the marginal zone to control the radial migration
of excitatory neurons, whereas a subpopulations of interneurons
mainly express this protein in the postnatal forebrain likely to
modulate synaptic function. In the cerebellum, Reelin is mainly
expressed by granule cells and granule cell precursors, controlling
the radial migration of Purkinje cells and possibly affecting
cerebellar circuit function. In addition, less-characterized cell
types also express Reelin in other regions of the brain and
spinal cord, affecting positioning and connectivity of several
neuronal target populations. A series of original research articles
in this Topic reveal novel aspects of Reelin expression and
function in the central nervous system. Carceller et al. describes
the phenotypical identity of unique Reelin-expressing cells in
the piriform cortex. Bosch et al. investigated the effects of
in vivo Reelin overexpression on the development of synaptic
structures in the adult hippocampus. They demonstrate striking
effects on the morphology of presynaptic as well as postsynaptic
structures. Furthermore, they show that Reelin overexpression
affects the trafficking of NMDA receptor subunits and associated
proteins from synaptic toward extrasynaptic and cytosolic sites,
thus modulating glutamatergic neurotransmission. Granule cell
dispersion in the dentate gyrus is frequently associated with
temporal lobe epilepsy in human patients. Using organotypic
slice cultures Orcinha et al. re-examined the previously noted
correlation between Reelin loss and granule cell dispersion
after seizures. They show that the central fragment of Reelin
rescues the abnormal migration of dentate cells, establishing
a causal relationship between Reelin loss and granule cell
dispersion in epilepsy. Cocito et al. focused on the cerebellum,
and documented alterations in neuronal proliferation and
apoptosis in the homozygous reeler mouse lacking Reelin.
Finally, Vaswani and Blaess review findings related to the
expression pattern and role of Reelin in the ventral brain stem
and spinal cord. They describe specific neuronal populations
that express either Reelin or components of the canonical
signaling pathway, and review data in support of the notion
that Reelin affects specifically the final stages of migration of its
cell targets. However, unlike the neocortex, Reelin appears to
regulate both tangential (midbrain and spinal cord) and radial
migration (hindbrain). Future work will be needed to clarify
the mechanism underlying these activities, and to determine
whether, as in the forebrain, Reelin affects the maturation
or synaptic function of brain stem and spinal cord target
neurons.
The association and possible involvement of Reelin
dysfunction in neuropsychiatric disorders is addressed by
several excellent reviews. Lammert and Howell discuss human
REELIN heterozygous mutations in autism spectrum disorder.
They describe the several de novo mutations identified so far
in autistic patients, their location and their potential effect on
Reelin protein structure and brain development. However, the
author caution that, given the lack of an autistic phenotype in
heterozygous reeler mice or in human subjects carrying REELIN
gene deletion, second-hit mutations, or environmental insults
may be necessary to develop the disease. Guidotti et al. delve
into the association between human REELIN dysfunction and
schizophrenia, and review the experimental evidence from post-
mortem human tissue and animal models pointing to epigenetic
mechanisms that cause reduced REELIN gene expression in
GABAergic corticolimbic neurons. The studies so far suggest
that this deficit may disrupt synaptic connectivity and predispose
human subjects not only to schizophrenia, but also to bipolar
disorder. Caruncho et al. focus on the role of Reelin in the
pathogenesis of depression, and discuss data from an animal
model of the disorder, produced by repeated corticosteroid
injections. This treatment causes the loss of Reelin-positive
cell in the subgranular zone of the dentate gyrus, where adult
neurogenesis takes place. Finally, Ishii et al. provide a thorough
summary and critical discussion of the human genetic and
experimental animal evidence relating Reelin dysfunction to
neuropsychiatric disorders, and emphasize how knowledge of
the Reelin signaling mechanisms could potentially be translated
into therapeutic intervention for neuropsychiatric disorders.
Overall, the data presented in this Topic provide strong
support for the idea that Reelin plays and essential role
of in brain development and in adult brain function, and
compel us to further investigate this protein’s function using
multidisciplinary approaches, including structural, cellular,
anatomical, physiological, and genetic approaches, in the hope
that the newly acquired knowledge will help us to develop much-
needed forms of pharmacological intervention for the treatment
of neuropsychiatric disorders.
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